12/4
07:45 am
ekso
Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch’s Groundbreaking BalanceTutor™ Rehabilitation System
High
Report
Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch’s Groundbreaking BalanceTutor™ Rehabilitation System
12/2
03:41 pm
ekso
Ekso Bionics (NASDAQ:EKSO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Neutral
Report
Ekso Bionics (NASDAQ:EKSO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/28
06:44 am
ekso
How Recent Moves Are Rewriting the Story for Ekso Bionics [Yahoo! Finance]
Medium
Report
How Recent Moves Are Rewriting the Story for Ekso Bionics [Yahoo! Finance]
11/19
07:00 am
ekso
Ekso Bionics (NASDAQ:EKSO) was given a new $6.00 price target on by analysts at HC Wainwright.
Medium
Report
Ekso Bionics (NASDAQ:EKSO) was given a new $6.00 price target on by analysts at HC Wainwright.
11/18
11:04 am
ekso
Ekso Bionics (NASDAQ:EKSO) had its price target raised by analysts at HC Wainwright from $4.00 to $6.00. They now have a "buy" rating on the stock.
Low
Report
Ekso Bionics (NASDAQ:EKSO) had its price target raised by analysts at HC Wainwright from $4.00 to $6.00. They now have a "buy" rating on the stock.
10/29
08:00 am
ekso
Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
Medium
Report
Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
10/28
04:05 pm
ekso
Ekso Bionics Reports Third Quarter 2025 Financial Results
Medium
Report
Ekso Bionics Reports Third Quarter 2025 Financial Results
10/24
12:21 pm
ekso
Ekso Bionics (NASDAQ:EKSO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Ekso Bionics (NASDAQ:EKSO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/14
09:47 am
ekso
Construction Exoskeleton Market Global Forecast Report 2025-2032: Technology, Supply Chain Considerations, and Competitive Dynamics Assessment [Yahoo! Finance]
Neutral
Report
Construction Exoskeleton Market Global Forecast Report 2025-2032: Technology, Supply Chain Considerations, and Competitive Dynamics Assessment [Yahoo! Finance]
10/8
12:20 pm
ekso
Ekso Bionics (NASDAQ:EKSO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Ekso Bionics (NASDAQ:EKSO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.